Assessment of Hematological Toxicity in Children with Acute Lymphoblastic Leukemia, Receiving Treatment with ALL IC-BFM 2009 Protocol

Journals Menu

Follow SCIRP

ISSN Print: 2333-9705
ISSN Online: 2333-9721
www.scirp.org/journal/oalibj
E-mail: service@oalib.com

"Assessment of Hematological Toxicity in Children with Acute Lymphoblastic Leukemia, Receiving Treatment with ALL IC-BFM 2009 Protocol"
written by Zeynep Canan Özdemir, Yeter Düzenli Kar, Ayşe Bozkurt Turhan, Özcan Bör,
published by Open Access Library Journal, Vol.4 No.8, 2017

has been cited by the following article(s):

[1]	MicroRNA gene methylation landscape in pediatric B-cell precursor acute lymphoblastic leukemia
	… in Clinical and …, 2022

[2]	The Role of SLC22A1 and Genomic Ancestry on Toxicity during Treatment in Children with Acute Lymphoblastic Leukemia of the Amazon Region
	Paes… - Genes, 2022

[3]	Eventos adversos a medicamentos durante el tratamiento de inducción de la leucemia linfoide aguda en niños
	Revista Cubana de …, 2021

[4]	Eventos adversos a medicamentos durante el tratamiento de inducciÃ³n de la leucemia linfoide aguda en niÃ±os
	2021

[5]	Considerations on the Hematologic Toxicity of the all IC-BFM 2002/2009 Therapeutic Protocol in Children with Acute Lymphoblastic Leukemia
	REVISTA DE …, 2019

Follow SCIRP

[1]	Clinical use of polyvalent intravenous immunoglobulins during intensive polychemotherapy in children with acute lymphoblastic leukemia Minerva Pediatrics, 2023 DOI:10.23736/S2724-5276.19.05494-X

[2]	The Role of SLC22A1 and Genomic Ancestry on Toxicity during Treatment in Children with Acute Lymphoblastic Leukemia of the Amazon Region Genes, 2022 DOI:10.3390/genes13040610